Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) and yttrium radioisotopes

1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) has been researched along with yttrium radioisotopes in 1 studies

Compound Research Comparison

Studies
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))
Trials
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))
Recent Studies (post-2010)
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))
Studies
(yttrium radioisotopes)
Trials
(yttrium radioisotopes)
Recent Studies (post-2010) (yttrium radioisotopes)
25483,4073391,533

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arani, SS; Maraghe, MG; Mehrabi, M; Salek, N; Samani, AB; Vosoghi, S1

Other Studies

1 other study(ies) available for 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) and yttrium radioisotopes

ArticleYear
Preparation and Dosimetry Evaluation of a Carrier- Free 90Y Labeled DOTMP as a Promising Agent for Bone Marrow Ablation.
    Current radiopharmaceuticals, 2018, Volume: 11, Issue:2

    Topics: Ablation Techniques; Animals; Bone Marrow; Femur; Lutetium; Mice; Models, Biological; Organophosphorus Compounds; Radiation Dosage; Radioisotopes; Rats, Wistar; Samarium; Tissue Distribution; Yttrium Radioisotopes

2018